These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4951221)

  • 21. Endometrial histology and clinical symptoms following prolonged retention of uterine contraceptive devices.
    Rozin S; Sacks MI; Shenker JG
    Am J Obstet Gynecol; 1967 Jan; 97(2):197-202. PubMed ID: 6017026
    [No Abstract]   [Full Text] [Related]  

  • 22. Calcified bodies and the intrauterine device.
    Highman WJ
    Acta Cytol; 1971; 15(5):473-5. PubMed ID: 4329490
    [No Abstract]   [Full Text] [Related]  

  • 23. Aminocaproic acid and menstrual loss in women using intrauterine devices.
    Kasonde JM; Bonnar J
    Br Med J; 1975 Oct; 4(5987):17-9. PubMed ID: 1174902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of silica shield intrauterine devices on menstrual blood loss and iron balance].
    Wu SC; Gao J
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):306-8, 320. PubMed ID: 4085300
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
    Milsom I; Andersson K; Andersch B; Rybo G
    Am J Obstet Gynecol; 1991 Mar; 164(3):879-83. PubMed ID: 1900665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intrauterine device of the DANA-super type as a long-term contraceptive].
    Berg J
    Zentralbl Gynakol; 1973 Dec; 95(50):1772-5. PubMed ID: 4780396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrauterine contraception using the copper-seven device.
    Newton J; Elias J; McEwan J
    Lancet; 1972 Nov; 2(7784):951-4. PubMed ID: 4116827
    [No Abstract]   [Full Text] [Related]  

  • 28. The Shanghai ring: two case reports and review of literature.
    Padavala J; Ashraf M
    J Obstet Gynaecol; 2009 Jan; 29(1):67-8. PubMed ID: 19280507
    [No Abstract]   [Full Text] [Related]  

  • 29. The relationship between endometrial mast cell count and bleeding in women following insertion of an intrauterine device.
    Mehra U; Devi PK; Chakravarti RN; Chaudhury RR
    Am J Obstet Gynecol; 1970 Jul; 107(6):852-6. PubMed ID: 4193675
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of complications caused by intrauterine devices].
    Fabiani G; Pittino M; D'Aietti V; Dalla Pria S; Zaccagna G
    Minerva Ginecol; 1987 Sep; 39(9):639-42. PubMed ID: 3683970
    [No Abstract]   [Full Text] [Related]  

  • 31. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
    Pan J; Yu Y; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices.
    Oyelola OO; Okonofua FE; Adediran TO
    East Afr Med J; 1994 Apr; 71(4):268-70. PubMed ID: 8062778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in menstrual bleeding caused by the use of the IUD].
    Pedrón Nuevo N
    Arch Invest Med (Mex); 1988; 19(3):245-52. PubMed ID: 3242436
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of intrauterine devices on subsequent fertility.
    Skjeldestad FE
    Curr Opin Obstet Gynecol; 2008 Jun; 20(3):275-80. PubMed ID: 18460943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinolytic activity in bleeding associated with intrauterine contraceptive devices.
    Khanna A; Biswas AK; Dubey B; Khanna AK
    Indian J Med Res; 1992 Jun; 96():147-9. PubMed ID: 1512035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ethamsylate and aminocaproic acid on menstrual blood loss in women using intrauterine devices.
    Kasonde JM; Bonnar J
    Br Med J; 1975 Oct; 4(5987):21-2. PubMed ID: 1174906
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased endometrial fibrinolytic activity as a cause of menometrorrhagia in women using IUD's.
    Surico N; Tavassoli K; Porcelli A; Ferraris G
    Panminerva Med; 1988; 30(3):184-7. PubMed ID: 3211578
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study on clinical efficacy and mechanism of xiaoyan zhixue capsule in treating menorrhagia caused by intrauterine device].
    Ren JF; Qu QH; Yu B; Liu Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Jul; 24(7):605-9. PubMed ID: 15307698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menstrual blood-loss with intrauterine devices.
    Guillebaud J; Bonnar J; Morehead J; Matthews A
    Lancet; 1976 Feb; 1(7956):387-90. PubMed ID: 55650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New model intrauterine contraceptive pessary--the Copper T 380 Ag].
    Vasilev D
    Akush Ginekol (Sofiia); 1987; 26(4):81-4. PubMed ID: 3674330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.